SR
Surapaneni Ramakrishna
About Surapaneni Ramakrishna
Surapaneni Ramakrishna has 33 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Satyadeeptha Pharmaceuticals Limited. Formerly with 3 companies, such as Tarunya Life Sciences Private Limited and Om Maritech Pvt Ltd. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Satyadeeptha Pharmaceuticals Limited
U85110KA1993PLC013900
|
Managing Director | 18 Jan 1993 | 1987 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Tarunya Life Sciences Private Limited
U74900KA2015PTC149790
|
Director | 11 Mar 2015 | 2015 | Active |
|
Om Maritech Pvt Ltd
U05005TG1994PTC017875
|
Director | 07 Jul 1994 | 1994 | Active |
Rampex Labs Private Limited
U24239TG2004PTC043271
|
Director | 18 May 2004 | 2004 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surapaneni Ramakrishna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surapaneni Ramakrishna
Surapaneni Ramakrishna has 33 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Satyadeeptha Pharmaceuticals Limited. Formerly with 3 companies, such as Tarunya Life Sciences Private Limited and Om Maritech Pvt Ltd. Engaged in General Business, Technology. Contributes to corporate operations.
Surapaneni Ramakrishna is associated with 1 company as Managing Director.
Surapaneni Ramakrishna has expertise in General Business, Technology.
Surapaneni Ramakrishna has 33 years in corporate governance.